ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 640212 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 640212; 2) Community: the network communities that were significantly associated with the response to NSC 640212; 3) Molecule: the relationships between components within communities and NSC 640212; 4) MDR: the compounds that were significantly associated with the NSC 640212.

NSC Compound Enrichment Correlation
NSC 633271 Null 0.00336064452966832 0.36200307
NSC 119875 Cisplatin 0.00356914129105574 0.21337975
NSC 176507 Fastigilin C 0.00356914129105574 0.53024626
NSC 292206 RUSTAIYAN A 0.00356914129105574 0.40195671
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.00356914129105574 0.35112479
NSC 46728 Crassin acetate 0.00356914129105574 0.33212112
NSC 645210 1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- 0.00356914129105577 0.44001512
NSC 645991 Null 0.00356914129105577 0.46167248
NSC 658828 Null 0.00356914129105577 0.43721719
NSC 683086 Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- 0.00356914129105577 0.21259548
Total:93  Current:14    [First] [Prev] [Next] [Last]